Stock Price

Mar 9 4:00 p.m. ET
delayed 20 minutes

TSX:MDS

PRICE: $8.57
CHANGE:0.07
VOLUME:816,800

NYSE:MDZ

PRICE: $8.33
CHANGE:0.06
VOLUME:439,300

Investor Information

120.1 million shares outstanding
(Jan 31, 2010)

Market cap of
C$950.3 million
(Jan 31, 2010)

Investor Overview

Welcome to the MDS Investor Relations section. Here you will find the latest information on the value of MDS — from financial data and shareholder services, to reports and events.

Corporate Profile:

MDS Inc. is a global health science company that provides market-leading products and services used for the prevention, diagnosis and treatment of disease. We are a leading provider of innovative technologies for use in medical imaging and radiotherapeutics, and sterilization technologies benefiting the lives of millions of people in more than 70 countries around the world.  Our products and services are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories.

MDS Nordion is a leading global provider of innovative technologies for medical imaging and radiotherapeutics, and sterilization. It operates in an estimated US$4 billion market. Learn more.

 

MDS was founded in 1969 and currently has more than 850 highly skilled people in five locations.

MDS trades on the Toronto Stock Exchange (TSX: MDS) and on the New York Stock Exchange (NYSE: MDZ).